MAB8251
抗-甲型流感病毒抗体，核蛋白，克隆A1、A3混合物
ascites fluid, Chemicon®, from mouse
登录 查看组织和合同定价。
选择尺寸
关于此项目
UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
Clone:
A1, monoclonal
A3, monoclonal
A3, monoclonal
Species reactivity:
human
Application:
immunofluorescence
Technique(s):
immunofluorescence: suitable
Citations:
69
产品名称
抗-甲型流感病毒抗体，核蛋白，克隆A1、A3混合物, ascites fluid, Chemicon®, from mouse
biological source
mouse
antibody form
ascites fluid
antibody product type
primary antibodies
clone
A1, monoclonal
A3, monoclonal
species reactivity
human
manufacturer/tradename
Chemicon®
technique(s)
immunofluorescence: suitable
isotype
IgG1 (A3)
IgG2a (A1)
shipped in
wet ice
Quality Level
Analysis Note
对照
流感病毒对照玻片，目录号5010-5
流感病毒对照玻片，目录号5010-5
Application
研究子类别
传染病 - 病毒
传染病 - 病毒
研究类别
传染病
传染病
该抗甲型流感病毒抗体，核蛋白，克隆A1、A3混合物经验证可用于IF检测甲型流感病毒。
间接免疫荧光（1:100-1:1000）。
最佳工作稀释度必须由最终使用者进行确定。
最佳工作稀释度必须由最终使用者进行确定。
Biochem/physiol Actions
甲型流感病毒的所有亚型（H1N1、H2N2和H3N2和H5N1）。对核蛋白抗原具有特异性。未见与乙型流感病毒、副流感病毒1型、副流感病毒2型或腺病毒或RSV的交叉反应性。
Disclaimer
除非我们的目录或产品随附的其他公司文件中另有说明，否则我们的产品预期仅用于研究用途，不得用于任何其他目的，包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或对人类或动物的任何类型的消费或应用。
Immunogen
甲型流感病毒混合物。
Other Notes
浓度：关于批次特定浓度请参见检验报告。
Physical form
不含防腐剂的腹水。
未纯化
Preparation Note
自收到之日起在-20°C可稳定保存1年。分装保存以避免反复冻融。为了最大程度地回收产品，需在融化后和取下盖子之前将原始样品管进行离心。
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
未找到合适的产品？
试试我们的产品选型工具.
存储类别
10 - Combustible liquids
wgk
nwg
flash_point_f
Not applicable
flash_point_c
Not applicable
Recipients of vaccine against the 1976 "swine flu" have enhanced neutralization responses to the 2009 novel H1N1 influenza virus.
McCullers, JA; Van De Velde, LA; Allison, KJ; Branum, KC; Webby, RJ; Flynn, PM
Clinical Infectious Diseases null
Maren Eggers et al.
Infectious diseases and therapy, 7(2), 249-259 (2018-04-11)
Recent virus epidemics and rising antibiotic resistance highlight the importance of hygiene measures to prevent and control outbreaks. We investigated the in vitro bactericidal and virucidal efficacy of povidone-iodine (PVP-I) 7% gargle/mouthwash at defined dilution against oral and respiratory tract
Higher level of replication efficiency of 2009 (H1N1) pandemic influenza virus than those of seasonal and avian strains: kinetics from epithelial cell culture and computational modeling.
Mitchell, H; Levin, D; Forrest, S; Beauchemin, CA; Tipper, J; Knight, J; Donart et al.
Journal of virology null
Benjawan Khuntirat et al.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 69, 78-80 (2015-07-26)
Influenza A/H5N1 actively circulated in Kamphaeng Phet (KPP), Thailand from 2004 to 2006. A prospective longitudinal cohort study of influenza virus infection in 800 adults conducted during 2008-2010 in KPP suggested that subclinical or mild H5N1 infections had occurred among
Shuguang Han et al.
Clinical and experimental pharmacology & physiology, 45(1), 84-93 (2017-08-31)
Curcumin, an active phenolic agent extract from the Curcuma longa, exhibits excellent anti-cancer, anti-inflammation, and neuroprotective effects. We aimed to investigate the anti-influenza role of curcumin in vitro and in vivo. The effect of curcumin on replication of influenza A
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持